← The Wire
XGNNasdaq
EXAGEN INC.
Services-Medical Laboratories · DE · CIK 1274737
Develops and commercializes innovative testing products for diagnosing and monitoring autoimmune diseases
red 8-K · 90d
$113M
Market cap
$4.75
Last close
+3.7%
1D
+7.5%
5D
152K
Volume
Price · last 39 sessions+53.2%
May 4L $2.94 · H $5.35Jun 29
145
Total filings
Jun 9, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 9, 202610-Q10-QMay 11, 20268-KResults of OperationsMay 11, 2026DEFA14ADEFA14AApr 27, 2026DEF 14ADEF 14AApr 27, 20268-KExecutive ChangeApr 23, 202610-K10-KMar 10, 20268-KResults of OperationsMar 10, 20268-KResults of Operations · Company UpdateJan 12, 202610-Q10-QNov 4, 20258-KResults of OperationsNov 4, 202510-Q10-QJul 29, 20258-KResults of OperationsJul 29, 20258-KExecutive Change · Company UpdateJul 17, 20258-KShareholder VoteJun 11, 20258-KCompany UpdateMay 9, 2025424B5424B5May 8, 20258-KMaterial Agreement · Company UpdateMay 8, 2025424B5424B5May 7, 202510-Q10-QMay 5, 20258-KResults of OperationsMay 5, 2025DEFA14ADEFA14AApr 30, 2025DEF 14ADEF 14AApr 30, 20258-KMaterial Agreement · New Debt / ObligationApr 28, 202510-K10-KMar 11, 20258-KResults of OperationsMar 11, 20258-KResults of Operations · Company UpdateJan 13, 202510-Q10-QNov 12, 20248-KResults of OperationsNov 12, 202410-Q10-QAug 5, 20248-KResults of OperationsAug 5, 20248-K/AExecutive Change · Company UpdateAug 2, 20248-KExecutive Change · Company UpdateAug 2, 20248-KShareholder VoteJun 11, 202410-Q10-QMay 13, 20248-KResults of OperationsMay 13, 2024DEFA14ADEFA14AApr 26, 20248-KExecutive Change · Company UpdateApr 26, 2024DEF 14ADEF 14AApr 26, 202410-K10-KMar 18, 20248-KResults of OperationsMar 18, 20248-KResults of OperationsJan 8, 20248-KExecutive ChangeDec 11, 2023424B5424B5Nov 29, 2023424B5424B5Nov 20, 20238-KMaterial AgreementNov 17, 202310-Q10-QNov 13, 20238-KResults of OperationsNov 13, 20238-KMaterial Agreement · Agreement TerminatedOct 26, 202310-Q10-QAug 7, 20238-KResults of OperationsAug 7, 20238-KExecutive Change · Company UpdateJul 24, 20238-KShareholder VoteJun 14, 2023DEFA14ADEFA14AMay 24, 202310-Q10-QMay 15, 20238-KResults of OperationsMay 15, 20238-KMaterial Agreement · New Debt / ObligationMay 4, 2023DEFA14ADEFA14AApr 28, 2023DEF 14ADEF 14AApr 28, 20238-KExecutive ChangeMar 23, 202310-K10-KMar 20, 20238-KResults of OperationsMar 20, 20238-KBylaw Amendment · Reg FD DisclosureJan 23, 20238-KResults of Operations · Reg FD DisclosureJan 9, 20238-KExecutive Change · Exit / Disposal CostsDec 5, 2022SC 13GSC 13GNov 23, 202210-Q10-QNov 21, 202210-Q/A10-Q/ANov 21, 20228-KRestatement · Results of OperationsNov 14, 20228-KExecutive Change · Reg FD DisclosureOct 20, 2022424B5424B5Sep 15, 20228-KMaterial AgreementSep 15, 202210-Q10-QAug 4, 20228-KResults of OperationsAug 4, 20228-KShareholder VoteJun 21, 202210-Q10-QMay 11, 20228-KResults of OperationsMay 11, 2022DEFA14ADEFA14AApr 28, 2022DEF 14ADEF 14AApr 28, 20228-KExecutive ChangeApr 28, 2022
Insider Activity
In the 90 days to Mar 3, 2026: 2 sold $104K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 3, 2026 | Aballi JohnPresident and CEO | Sell | 15,698 | $3.62 | $57K |
| Feb 24, 2026 | Aballi JohnPresident and CEO | Sell | 11,430 | $3.61 | $41K |
| Feb 24, 2026 | Black Jeffrey G.Chief Financial Officer | Sell | 1,584 | $3.61 | $6K |
| Oct 16, 2025 | Aballi JohnPresident and CEO | Sell | 31,787 | $11.82 | $376K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance